SEC Form 4 · accession 0001209191-19-017476
Krystal Biotech, Inc. · KRYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian S Gangolli
Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 6, 2019 · 5:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711279
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.75 | Mar 1, 2019 | A | 20,000 | A | Mar 1, 2022 | Mar 1, 2029 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The options were awarded on March 1, 2019 and vest monthly over a three-year period.